Hemoglobin levels in persons with depressive and/or anxiety disorders

https://doi.org/10.1016/j.jpsychores.2014.01.004Get rights and content

Abstract

Objective

Both low and high hemoglobin levels lead to more physical diseases, and both are linked to mortality. Low hemoglobin, often classified as anemia, has also been linked to more depressive symptoms, but whether both hemoglobin extremes are associated with depressive disorder and potentially also with anxiety disorder has not been examined before. This study examines to which extent hemoglobin levels are associated with depression and anxiety disorders in a large cohort.

Methods

The study sample consisted of 2920 persons from the Netherlands Study of Depression and Anxiety. Hemoglobin levels were determined after venipuncture. Depressive and anxiety disorders were determined according to a DSM-IV-based psychiatric interview. Clinical psychiatric characteristics included the severity of depression and anxiety, the duration of symptoms, the age of onset and the antidepressant use.

Results

Higher hemoglobin levels were found in those with current depressive and/or anxiety disorders after sociodemographic adjustment and both higher, and lower hemoglobin levels were found in persons with higher depression and anxiety severity. However, after full adjustment for sociodemographics, disease indicators and lifestyle, associations were no longer significant.

Conclusions

This cohort study showed that there is no independent association between depressive and/or anxiety disorders and hemoglobin levels or anemia status.

Introduction

Extreme hemoglobin levels (Hb), both low and high levels, lead to deteriorated quality of life [1], [2], have been associated with greater mortality in elderly persons [2], [3] and have been linked to the development of diseases, such as heart failure or cardiovascular diseases (for low hemoglobin levels) [4], [5] and hypertension or thrombosis (for high hemoglobin levels) [6].

Beyond these physical health problems, previous research has shown that low hemoglobin level (anemia) is associated with more depressive symptoms [7], [8], [9], [10], [11]. Such an association could be expected since symptoms of low hemoglobin level (paleness, fatigue, dizziness, shortness of breath during physical activity, higher heart beat in resting state and heart fluttering) also often occur when having depressive (or anxiety) symptoms. This association between low hemoglobin level and depression could potentially be explained by underlying poorer physical health status such as fatigue [12], [13], [14], reduced levels of brain oxygen [15], vitamin B12 deficiency [16], [17], [18] or higher inflammatory levels [19], [20], [21]. Earlier studies on anemia and depression included elderly or diseased persons only and did generally not consider the presence of psychiatric disorders but used self-report measures of depressive symptomatology. Consequently, whether low hemoglobin levels are associated with psychiatric depression in a younger adult sample needs to be clarified. In addition, whether an association between anemia and mental health extends to anxiety disorders, a highly comorbid condition to depression with partly shared pathophysiology, needs to be established as well. Furthermore, whether high hemoglobin levels are also associated with depressive and anxiety disorders has not been examined before. Such an association could be expected since both high hemoglobin and depressive and anxiety disorders are associated with vascular disease [6], [22], [23] and smoking [24], [25] probably due to increased blood viscosity [26].

This cohort study examines the association between hemoglobin levels and the presence of depressive and anxiety disorders in an adult population. Both the low end and the high end of the hemoglobin spectrum will be distinguished, considering the fact that both ends have been associated with poorer health. We also examined whether an association between low or high hemoglobin levels and psychiatric disorders is dependent on clinical psychiatric characteristics, such as severity, duration, age of onset of the depressive or anxiety disorder and antidepressant use.

Section snippets

Study sample

The Netherlands Study of Depression and Anxiety (NESDA) is an ongoing longitudinal cohort study that investigates the long-term course and consequences of depressive and anxiety disorders. During a 4-hour measurement, a wide range of data were collected, including the assessment of demographics, a diagnostic psychiatric interview and a medical examination including blood collection. All respondents signed an informed consent. The NESDA protocol was approved by the ethical review board of all

Results

The mean age of the study sample was 41.9 ± 13.1 years, 66.3% was women and the mean years of education was 12.2 ± 3.3 years. The mean hemoglobin level was 13.9 g/dl (SD = 1.3 g/dl), 7.3% had anemia according to the WHO cutoff and 7.9% had high hemoglobin levels (Hb ≥ 3.1 g/dl above anemia cutoff). Table 1 shows characteristics of the study sample across the different hemoglobin categories. The hemoglobin groups differed from each other: those with anemia were younger, were more often women, had more years

Discussion

This large cohort study comprehensively examined the role of hemoglobin levels in depression and anxiety. The current study provides no clear evidence for an association between depression/anxiety and hemoglobin levels. Higher hemoglobin levels were found in those with current depressive and/or anxiety disorders after sociodemographic adjustment, and both higher and lower hemoglobin levels were found in persons with higher depression and anxiety severity. However, after full adjustment for

Conflict of interest

All authors declare that they have no competing interests to report.

Acknowledgements

The infrastructure for the NESDA study is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-MW, grant no. 10-000-1002) and is supported participating universities and mental health care organizations (VU University Medical Center, GGZinGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, IQ Healthcare, Netherlands Institute for Health Services

References (38)

  • A Kilicgedik et al.

    Anemia in heart failure

    Anadolu Kardiyol Derg

    (2012)
  • E O'Riordan et al.

    Effects of anaemia on cardiovascular status

    Nephrol Dial Transplant

    (2000)
  • JM Gomez et al.

    What should the optimal target hemoglobin be?

    Kidney Int Suppl

    (2002)
  • WP den Elzen et al.

    Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study

    CMAJ

    (2009)
  • M Hamer et al.

    Cross-sectional and longitudinal associations between anemia and depressive symptoms in the English Longitudinal Study of Ageing

    J Am Geriatr Soc

    (2009)
  • G Onder et al.

    Anemia is associated with depression in older adults: results from the InCHIANTI study

    J Gerontol A Biol Sci Med Sci

    (2005)
  • A Steptoe et al.

    Anaemia and the development of depressive symptoms following acute coronary syndrome: longitudinal clinical observational study

    BMJ Open

    (2012)
  • R Stewart et al.

    Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population

    Psychosom Med

    (2012)
  • M Cesari et al.

    Hemoglobin levels and skeletal muscle: results from the InCHIANTI study

    J Gerontol A Biol Sci Med Sci

    (2004)
  • Cited by (39)

    • Association between anemia and depression: The 2014, 2016, and 2018 Korea National Health and Nutrition Examination Survey

      2022, Journal of Affective Disorders
      Citation Excerpt :

      Meanwhile, one study on the relationship between anemia and depression in premenopausal women did not show a significant association (Hunt and Penland, 1999). Another study also reported that the association between anemia and depression was not significant after adjusting for potential confounders (Lever-van Milligen et al., 2014). To our best knowledge, studies investigating the association between anemia and depression in a large national sample population are scarce.

    • Prediction of depression among medical check-ups of 433,190 patients: A nationwide population-based study

      2020, Psychiatry Research
      Citation Excerpt :

      Several studies have reported that each hematological factor is associated with depression. Low hemoglobin may increase the risk of depression in the elderly and is an indicator of poor health status and nutrition intake (Chen et al., 2012; Lever-van Milligen et al., 2014; Trevisan et al., 2016). This can be interpreted as related to the main symptoms of depression, such as fatigue and loss of energy; however, it is necessary to be careful in interpreting the relationship between the results of variables importance and depression in only one direction.

    • Depression, antidepressants and low hemoglobin level in the Paris Prospective Study III: A cross-sectional analysis

      2020, Preventive Medicine
      Citation Excerpt :

      As regards chronic diseases, the participants were required to indicate whether they had a history of hypertension, peripheral artery disease, stroke, myocardial infarction, angina, heart murmur, any other cardiac disease, hepatitis, peptic ulcer, cholelithiasis, intestinal polyp, thyrosis, kidney disease or cancer. In line with previous studies, participants were excluded from the present study if they had high hemoglobin level (>15.0 g/dl (9.30 mmol/l) in women and > 16.0 g/dl (9.90 mmol/l) in men) (Ren et al., 2014; Lever-Van Milligen et al., 2014) as they may be at high risk for depressive symptoms (Lever-Van Milligen et al., 2014). The PPS3 was registered in the World Health Organisation (WHO) International Clinical Trial Registry Platform (NCT00741728) in 25 August 2008.

    • Hemoglobin-derived peptides and mood regulation

      2020, Peptides
      Citation Excerpt :

      However, the use of Hb as a mark of mood is insufficient. A comprehensive cohort study which examined the role of Hb levels in depression and anxiety found that those with current depressive and/or anxiety disorders had increased Hb levels after adjusting for sociodemographic factors, whereas those with more severe depression and anxiety disorders had both increased and decreased Hb levels [15]. Hence, Hb is not always a reliable gauge of the state of mood, thereby raising the question that other molecules may better indicate the mood status.

    View all citing articles on Scopus
    View full text